Target: ATG9B
Conjugate: HRP
Product Type: Polyclonal
Immunogen: Synthetic peptide from the N-terminal of Human ATG9B (aa. 110-121)
Swiss-Prot: Q674R7
Purification: Peptide Affinity Purified
Storage Buffer: 73.64mM Carbonate, 54.55mM Ethanolamine, 45.45mM Cyanoborohydride, 18.18mM Sodium Hydroxide and 0.23mM Citrate in dH2O
Concentration: 1 mg/ml
Specificity: Detects ~100 kDa.
Cellular Localization: Cytoplasmic Vesicle / Autophagosome Membrane / Multi-Pass Membrane Protein
Tissue Specificity: Highly expressed in placenta (trophoblast cells) and pituitary gland. Not expressed in vascular endothelial.
Scientific Background: ATG9B is involved in autophagy and cytoplasm to vacuole transport (Cvt) vesicle formation. Plays a key role in the organization of the preautophagosomal structure/phagophore assembly site (PAS), the nucleating site for formation of the sequestering vesicle. Highly expressed in the placenta and the pituitary gland.
References: 1. http://www.uniprot.org/uniprot/Q674R7
Field of Use: Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
Deutsch
English
